Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface

We discovered distinct as well as shared molecular pathways associated with RPL pathogenesis before and after the start of placental circulation and identified novel biomarkers for these pathways which have outstanding discriminative properties. Our results may facilitate a better understanding of the molecular pathways of RPL. However, larger clinical studies are needed to investigate whether the identified biomarkers also have predictive power for RPL before pregnancies fail and to test drugs for the modulation of the identified disease pathways and the prevention of RPL. Our findings highlight the importance of the maternal immune system in maintaining successful pregnancy and suggest that targeting immune pathways may offer novel therapeutic approaches for RPL.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-08-28
DOI
https://doi.org/10.3389/fimmu.2025.1621168
Citations
1
Primary Topic
Reproductive System and Pregnancy
Type
article
Field-Weighted Citation Impact
0.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface

Eszter Tóth, Nándor Gábor Than, Nándor Ács, Máté Posta et al.
1 citations
Frontiers in Immunology
Reproductive System and Pregnancy
0.80
article

Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface

Eszter Tóth, Nándor Gábor Than, Nándor Ács, Máté Posta, Claudia Escher, Sándor Nagy, Dániel Györffy, Petronella Hupuczi, Olga Török, Orsolya Oravecz, Oliver Rinner, L Veress, Offer Erez, András Szilágyi, Andrea Balogh, Zoltán Papp, Magdalena Bober, E Farkas
article en
1 citations

Abstract

We discovered distinct as well as shared molecular pathways associated with RPL pathogenesis before and after the start of placental circulation and identified novel biomarkers for these pathways which have outstanding discriminative properties. Our results may facilitate a better understanding of the molecular pathways of RPL. However, larger clinical studies are needed to investigate whether the identified biomarkers also have predictive power for RPL before pregnancies fail and to test drugs for the modulation of the identified disease pathways and the prevention of RPL. Our findings highlight the importance of the maternal immune system in maintaining successful pregnancy and suggest that targeting immune pathways may offer novel therapeutic approaches for RPL.

Frontiers in ImmunologyVol. 16
Semmelweis University (HU), Eötvös Loránd University (HU), Ben-Gurion University of the Negev (IL), University of Debrecen (HU), Pázmány Péter Catholic University (HU), Maternity Foundation (DK), Biognosys (Switzerland) (CH), HUN-REN Research Centre for Natural Sciences (HU), Széchenyi István University (HU)
European Commission, Hungarian Scientific Research Fund, Magyar Tudományos Akadémia, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
Openalex Percentile: Top 24%
Reproductive System and Pregnancy
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.